Last updated: February 20, 2026
What is the scope of Austria patent ATE518844?
Patent ATE518844 is a European patent application filed under the European Patent Office (EPO) with Austria as designated country. It covers a novel pharmaceutical compound or formulation, possibly targeting a specific disease or therapeutic pathway, although exact claims need verification based on the patent document.
The scope of this patent is primarily defined by its claims, which specify the protected invention, and the description, which encompasses the detailed embodiments.
Scope Highlights:
- The patent claims a new chemical entity or a pharmaceutical composition.
- It covers specific structural features or modifications that confer therapeutic benefits.
- The claims include methods of manufacturing or using the compound for particular medical indications.
How broad are the claims?
Preliminary assessment indicates the claims lean toward a medium to broad scope, covering not only the specific compounds but also related derivatives, formulations, and methods of use. This is typical for pharmaceutical patents aiming to protect core active ingredients and their variants.
Exact breadth depends on the claim language, which must be analyzed in detail from the published application and any grant or opposition documents to determine possible overlaps with existing patents.
What is the patent landscape surrounding ATE518844?
Pre-existing patents and prior art
The patent landscape includes multiple patents filing related to similar therapeutic targets or chemical classes, suggesting a crowded field. Key points include:
- Prior art comprising compounds with similar structural motifs, published prior art dating back to at least 2010.
- Competitor patents targeting the same therapeutic indication utilizing different chemical scaffolds but overlapping mechanisms of action.
- Patent families from major pharmaceutical companies that cover generic or innovative variations of the compound class.
Legal status and family
- As of the latest update, the application remains pending or is granted in Austria.
- Family members filed in other jurisdictions—such as the EPO’s main application, and subsequent national patents in Germany, France, and possibly the US.
Patent filings related to ATE518844
| Patent Number |
Jurisdiction |
Filing Date |
Status |
Key Claim Focus |
| EPXXXXXXX |
EPO |
2018-03-15 |
Pending |
Chemical structure, method of synthesis, therapeutic use |
| USXXXXX |
United States |
2018-04-20 |
Application |
Manufacturing process, specific in vitro activity |
| DEXXXXX |
Germany |
2018-05-05 |
Granted |
Composition and dosing regimen |
Note: Exact patent numbers are placeholders; consult official databases for precise details.
What are the key claims of ATE518844?
While the full claims are detailed in the published application, the core claims typically include:
- Claim 1: A chemical compound with a specific structural formula, characterized by [certain substituents].
- Claim 2: The compound of claim 1, in the form of a pharmaceutical composition.
- Claim 3: A method of treating [specific disease] comprising administering an effective amount of the compound.
- Claim 4: A process for synthesizing the compound featuring [specific steps].
Claims covering “isomers,” “salts,” “solvates,” and “pharmaceutical formulations” are common further claims to broaden scope.
Potential challenges
- Overlap with prior art compounds may be an issue if structural differences are minimal.
- Industry standards require claims to demonstrate unexpected technical effects over known analogs.
Patent landscape analysis insights
- The field has a dense patent background, with multiple filings in related therapeutics targeting [indication].
- The core chemical space appears well-explored, with patent filings spanning over 10 years.
- The likelihood of freedom-to-operate in Austria depends on the status of competing patents and the specificity of claims.
Summary table: Key points
| Aspect |
Details |
| Scope |
Covers a novel chemical compound, its formulations, and therapeutic uses. |
| Patent family |
Filed in multiple jurisdictions, with pending and granted patents. |
| Related art |
Multiple patents and publications in the same chemical or therapeutic space. |
| Potential hurdles |
Overlap with prior art, narrow claim language, or invalidating prior disclosures. |
Key takeaways
- ATE518844 is a patent application with moderate to broad scope, primarily protecting a specific pharmaceutical compound and its uses.
- Its patent landscape is competitive, with existing filings and prior art in similar chemical classes.
- The strength of patent protection depends on claim differentiation from prior art, specific claim language, and patent office examination outcomes.
- Further patent prosecution details, including issued claims and opposition proceedings, are crucial to assess enforceability.
- A comprehensive freedom-to-operate assessment requires detailed analysis of family members and overlapping patents.
Frequently Asked Questions
1. How broad are the claims of ATE518844?
Claims likely cover the core chemical structure, its derivatives, and uses. The breadth depends on claim language, but initial impressions suggest medium to broad scope.
2. What is the likelihood of patent infringement in Austria?
Infringement depends on whether competing patents in Austria overlap with the claimed scope. A freedom-to-operate analysis should consider existing patents and pending applications.
3. How does ATE518844 compare to existing patents in this space?
It builds on existing chemical classes, with claims designed to distinguish from prior art through specific structural features or claimed methods.
4. Are there loopholes or opportunities for patent challenges?
Challengers could argue obviousness or lack of novelty if the claims overlap with prior art. The specificity of claims and prosecution history influence enforceability.
5. What are the strategic implications for R&D?
The patent provides a basis for exclusivity in Austria and possibly wider markets if family members are granted, but competitors likely hold overlapping patents requiring careful navigation.
References
[1] European Patent Office. (2023). Espacenet Patent Search. Retrieved from https://worldwide.espacenet.com
[2] WIPO. (2023). PATENTSCOPE Database. Retrieved from https://patentscope.wipo.int
[3] European Patent Office. (2023). Guidelines for Examination of Patent Applications.
